| Q91063329 | A novel GPR55-mediated satiety signal in the oval Bed Nucleus of the Stria Terminalis |
| Q38917434 | Advances in the Physiology of GPR55 in the Central Nervous System |
| Q40083785 | Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. |
| Q64230383 | Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity |
| Q36237457 | Circulating Irisin Levels Are Not Regulated by Nutritional Status, Obesity, or Leptin Levels in Rodents. |
| Q52148259 | Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity. |
| Q36219994 | Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation |
| Q38924783 | Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions. |
| Q26771102 | Lysophosphatidylinositol Signalling and Metabolic Diseases |
| Q38702653 | Lysophosphatidylinositol-induced activation of the cation channel TRPV2 triggers glucagon-like peptide-1 secretion in enteroendocrine L cells |
| Q92411354 | Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding |
| Q33822403 | The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice. |
| Q35425244 | The therapeutic potential of orphan GPCRs, GPR35 and GPR55. |